[Effects, on clinical and biohumoral constants, of cobamide and dimetazine treatment in infantile dystrophy].
D000731:Androstanes / Q000627:therapeutic use*; D000732:Androstanols; D001798:Blood Proteins / Q000032:analysis; D001835:Body Weight / Q000187:drug effects; D002675:Child, Preschool; D003038:Cobamides / Q000627:therapeutic use*; D004338:Drug Combinations; D005938:Glucocorticoids / Q000627:therapeutic use*; D006454:Hemoglobins / Q000096:biosynthesis; D006801:Humans; D007094:Imides / Q000627:therapeutic use; D007223:Infant; D007228:Infant Nutrition Disorders / Q000188:drug therapy*; D013412:Sulfadimethoxine / Q000627:therapeutic use*
D000731:Androstanes; D000732:Androstanols; D001798:Blood Proteins; D003038:Cobamides; D004338:Drug Combinations; D005938:Glucocorticoids; D006454:Hemoglobins; D007094:Imides; D013412:Sulfadimethoxine; C010216:mebolazine
L'influenza sulle costanti cliniche e bioumorali del trattamento con cobamamide e dimetazine nella distrofia del lattante